Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-121.18	-10.17	-4.60
Graham Fair Price	41.42	0.34	0.24
PEG	-66.09	-0.03	0.08
Price/Book	28.21	0.42	0.33
Price/Cash Flow	-38.73	5.60	9.14
Prices/Earnings	35.90	-2.57	-4.01
Price/Sales	-35.90	0.85	1.32
Price/FCF	-38.73	5.60	9.14
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.25	0.25
Operating Margin	0.00	-0.07	-0.07
ROA	-100.00	-0.03	-0.01
ROE	-0.02	-0.04	-100.00
ROIC	-0.02	-0.03	-96.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.12	-0.48	-74.34
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.79	-1.00	27.14
EPS QOQ	0.53	-1.00	89.02
FCF QOQ	1.38	1.09	-20.71
Revenue QOQ	-0.51	1.00	95.72
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	194.92	97.46	-50.00
Days Sales Outstanding (DSO)	106.45	65.73	-38.25
Inventory Turnover	0.46	0.92	100.00
Debt/Capitalization	0.13	0.15	10.42
Quick Ratio	3.51	4.52	28.75
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.36	0.36	0.00
Cash	0.16	0.21	32.28
Capex	< 0.005	< 0.005	-100.00
Free Cash Flow	0.01	0.03	109.25
Revenue	0.09	0.18	100.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	6.70	6.70	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	18.62	14.09	-24.35
Naive Interpretation	Member

06 - Financial Health · Bad

Rating